Brii Biosciences Monoclonal Antibodies, BRII-196 and BRII-198, Progress to Phase 3 in NIH ACTIV ...

Retrieved on: 2021-04-29 12:22:30

Tags for this article:

Health sciences

Drug discovery

Life Sciences

National Institute of Allergy and Infectious Diseases

Therapy

AIDS Clinical Trials Group

Brii Biosciences

Click the tags to see associated articles and topics

Brii Biosciences Monoclonal Antibodies, BRII-196 and BRII-198, Progress to Phase 3 in NIH ACTIV .... View article details on hiswai:

Excerpt

... today announced that its monoclonal antibody combination therapy, BRII-196 and BRII-198, met pre-specified safety and efficacy criteria, permitting ...

Article found on: www.valdostadailytimes.com

View Original Article